Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol

Pitcher-Wilmott R.W. , Levinsky R.J. , Gordon I. , Turner M.W. , Matthew D.J. Pseudomonas infection, allergy and cystic fibrosis. Arch Dis Childhood 1982; 57: 582–6.

Hodson M.E. , Penketh A.R.L. , Batten J.C. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infections in patients with cystic fibrosis. Lancet 1981; ii: 1137–9.

Mukhopadhyay S. , Singh M. , Cater J.I. , Ogston S. , Franklin M. , Olver R.E. Nebulised anti-pseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks. Thorax 1996; 51: 364–8.

Mukhopadhyay S. , Staddon G.E. , Eastman C. , Palmer M. , Rhys Davies E. , Carswell F. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Resp Med 1994; 88: 203–11.

Ilowite J.S. , Gorvoy J.D. , Smalldone G.C. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Resp Dis 1987; 136: 1445–9.

Mendelman P.M. , Smith A.L. , Levy J. , Weber A. , Ramsey B. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Resp Dis 1985; 132: 761–5.

Lefebvre C. The Cochrane Collaboration: the role of the UK Cochrane Centre in identifying the evidence. Health Library Rev 1994; 11: 235–42.

Mutch N. Inhalation of chemotherapeutic substances. Lancet 1994; 16: 775–80.

Pitcher-Wilmott R.W. , Levinsky R.J. , Gordon I. , Turner M.W. , Mathew D.J. Pseudomonas infection, allergy and cystic fibrosis. Archives of Disease in Childhood 1982; 57: 582–6.

Fuchs H.J. , Borowitz D.S. , Christiaansen D.H. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. New England Journal of Medicine 1994; 331: 637–42.

Mulherin D. , Ward K. , Coffey M. , Keoghan M.T. , Fitzgerald M. Cystic fibrosis in adolescents and adults. Irish Medical Journal 1991; 84: 121–4.

Schulz K. , Chalmers I. , Hayes R.J. , Altman D.G. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995; 273: 408–12.